Engineering Metabolically Fit, Memory-Rich CAR T Cells for Treatment of Cancer

Attend this keynote webinar presentation exploring advanced CAR T cell engineering strategies for enhanced cancer treatment effectiveness. Learn from Dr. Sarwish Rafiq, Assistant Professor at Emory School of Medicine's Department of Hematology and Medical Oncology, as she presents cutting-edge research on developing metabolically optimized CAR T cells with improved memory characteristics. Discover how novel engineering methods can create CAR T cells enriched with memory phenotypes that demonstrate superior metabolic fitness for treating both hematological malignancies and solid tumors. Explore the challenges facing current CAR T cell therapies, including the complex immunosuppressive tumor microenvironments and checkpoint pathway exploitation that allow tumors to evade immune responses. Understand why only a subset of patients achieve durable complete responses with existing CAR T cell treatments and how these innovative approaches aim to overcome significant obstacles in solid tumor treatment. Participate in the live Q&A session to engage directly with the research findings and gain insights into the translational applications of these mechanistic discoveries in immune effector cell function against cancer cells within tumor microenvironments.